Yahoo Web Search

Search results

    • BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

      Digital Journal· 4 days ago

      ...TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, today announced it has closed its previously announced registered direct offering with healthcare-focused institutional investors and a certain existing...